Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2025-03-26 Earnings Release
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
Full-year results for 2024 down against a backdrop of transformation, product range expansion and strategic investments to drive tomorrow's growth
Earnings Release Classification · 100% confidence The document explicitly states: "Intrasense (ISIN : FR0011179886), a French expert in medical imaging solutions facilitating diagnosis, decision-making, and therapeutic follow-up, announces the publication of its 2024 annual results and its new strategic roadmap." It then presents detailed financial tables for 2024 vs 2023, discusses operating income, EBITDA, net income, cash flow, and outlines a new strategic roadmap with financial targets for 2025 and 2027. The presence of full-year financial data (Revenue, EBITDA, Net Income) and the explicit mention of '2024 annual results' strongly indicate this is the primary annual financial disclosure. Although it contains strategic elements typical of an Investor Presentation (IP) or Management Discussion (MDA), the core content is the audited annual financial performance. Since it covers the full fiscal year and includes detailed financial statements, it aligns best with the Annual Report (10-K) category, even if it is presented as a press release format (which often precedes or summarizes the formal 10-K filing). Given the comprehensive nature of the financial review, 10-K is the most appropriate classification for the underlying report being announced/summarized. FY 2024
2025-03-26 English
DUOnco TM Bone : premier algorithme d’IA marqué CE pour la détection automatique des lésions osseuses sur les scanners CT
Regulatory Filings Classification · 95% confidence The document is a press release dated March 18, 2025, announcing that Intrasense and Guerbet have obtained the CE marking under MDR for their AI solution, DUOnco™ Bone, for detecting bone lesions on CT scans. This is a significant corporate announcement regarding a product milestone (regulatory approval) and partnership development. It is not a formal regulatory filing like a 10-K, an earnings release (ER), a dividend notice (DIV), or a management discussion (MDA). Since it is a specific announcement about a major business/product development that doesn't fit the other specific categories (like M&A, Capital Change, or Director Dealing), it falls best under the general 'Regulatory Filings' (RNS) category as a broad regulatory/corporate announcement, or potentially a general 'Report Publication Announcement' (RPA) if it were announcing the publication of a formal report, but here it announces a regulatory achievement (CE marking). Given the nature of announcing a regulatory approval for a medical device, RNS (Regulatory Filings) is the most appropriate general category for non-standard, material announcements.
2025-03-18 French
DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan
Regulatory Filings Classification · 95% confidence The document is a press release dated March 18, 2025, announcing that Intrasense and Guerbet have received CE marking under MDR for their AI solution, DUOnco™ Bone, for detecting bone lesions on CT scans. It details the product's features, clinical impact, and strategic positioning. This type of announcement, which is a general corporate update regarding a product/regulatory milestone but is not a formal financial report (like 10-K, IR, ER) or a specific regulatory filing (like DIRS, DIV), fits best under the general 'Regulatory Filings' or 'Report Publication Announcement' category if it were announcing a report. Since this is a product/regulatory milestone announcement, and it doesn't fit the specific definitions for financial reports, management changes, or shareholder actions, it is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if it were about fundraising, but here it is about a regulatory approval (CE Mark). Given the options, RNS serves as the best general regulatory/corporate announcement fallback for non-standard filings. However, since it is a detailed announcement of a significant corporate/product development, and not just a brief notice, RNS is the most appropriate general category for this type of press release that doesn't fit the other specific financial or corporate action codes.
2025-03-18 English
RECTIFICATIF - Agenda financier 2025
Report Publication Announcement Classification · 99% confidence The document is titled "RECTIFICATIF - Agenda financier 2025" (CORRECTION - Financial Agenda 2025). It announces the publication of the financial calendar for the year 2025. This is a communication about the timing of future financial reports, not the reports themselves. Since it is an announcement regarding the publication schedule of company reports, it fits best under 'Report Publication Announcement' (RPA). The document is short (under 5,000 characters) and serves to inform stakeholders about when future reports will be released, aligning with the 'MENU VS MEAL' rule for RPA classification.
2025-02-24 French
Présentation de la solution Liflow® lors de l’événement AI Action Summit à Paris, dans le cadre de la Semaine de l’Action pour l’IA
Regulatory Filings Classification · 95% confidence The document is a press release dated February 12, 2025, detailing the company Intrasense's participation and presentation of its Liflow® solution at the 'AI Action Summit' in Paris. It includes quotes from the CEO, descriptions of the technology, and contact information for communications and investor relations. This format—a formal announcement about a company event, product demonstration, or general corporate update that is not a mandatory regulatory filing (like 10-K, ER, or IR)—most closely aligns with a general corporate announcement or press release. Since there is no specific category for a general press release detailing participation in an industry event, and it is not a formal financial report, management change, or shareholder vote result, the most appropriate fallback category is 'Regulatory Filings' (RNS), which often serves as a catch-all for significant, non-standard announcements, or potentially 'Investor Presentation' (IP) if it were structured as a slide deck, but this reads like a news item. Given the context of providing updates to the market about strategic activities, RNS is the best fit among the provided options for a non-financial, non-management-specific announcement.
2025-02-12 French
Un chiffre d’affaires annuel 2024 à 2,2 M€
Earnings Release Classification · 100% confidence The document is a press release from Intrasense announcing its annual revenue for 2024. It provides key financial highlights, geographic revenue breakdowns, and commentary on business performance, governance changes, and future outlook. It is not a full annual report (10-K) but rather an initial announcement of financial results, which fits the definition of an Earnings Release (ER). FY 2024
2025-02-06 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.